{
    "paper_id": "PMC7361001",
    "metadata": {
        "title": "Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials",
        "authors": [
            {
                "first": "Juan",
                "middle": [
                    "A."
                ],
                "last": "Siordia",
                "suffix": "Jr",
                "email": "jas@email.arizona.edu",
                "affiliation": {}
            },
            {
                "first": "Michael",
                "middle": [],
                "last": "Bernaba",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Kenji",
                "middle": [],
                "last": "Yoshino",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Abid",
                "middle": [],
                "last": "Ulhaque",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Sooraj",
                "middle": [],
                "last": "Kumar",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Mario",
                "middle": [],
                "last": "Bernaba",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Edward",
                "middle": [],
                "last": "Bergin",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV2) is a novel coronavirus responsible for causing coronavirus disease 19 (COVID-19). It quickly became a pandemic in the beginning of 2020. Originating in Wuhan, China, the virus rapidly spread to other countries of the world [1]. On January 30, 2020, the World Health Organization (WHO) declared SARS-CoV2 a Public Health Emergency of International Concern (PHEIC) [2]. Medications are quickly being tested to assess for a suitable treatment regimen for the novel virus. The following systematic and statistical review assesses the current evidence regarding human controlled COVID-19 treatment trials.",
            "cite_spans": [
                {
                    "start": 284,
                    "end": 285,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 424,
                    "end": 425,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "An electronic search compiled human controlled studies analyzing treatments for COVID-19. Medical therapies investigated included lopinavir/ritonavir, arbidol, hydroxychloroquine, remdesivir, favipiravir, heparin, glucocorticoids, interferon, ivermectin, and convalescent plasma. Inclusion criteria included needing a control (whether standard therapy, placebo, or another medication) and testing among human subjects with COVID-19. In vitro and animal studies plus those without controls were not included in the review.",
            "cite_spans": [],
            "section": "Data Collection ::: Methods",
            "ref_spans": []
        },
        {
            "text": "Databases included Google Scholar and Pubmed. Key words included COVID-19, SARS-CoV2, randomized, controlled, human, retrospective, prospective, trial, chloroquine, hydroxychloroquine, lopinavir, ritonavir, arbidol, umifenovir, tocilizumab, favipiravir, steroids, dexamethasone, glucocorticoids, interferon, ivermectin, remdesivir, azithromycin, heparin, and low-molecular weight heparin. Abstracts and titles were reviewed for relevancy. Studies that had human subjects and a control arm were included in the study; otherwise, they were excluded. Duplicated studies were removed. The studies were organized based on the study medication; some studies presented more than one study medication and were included in more than one group. Statistical analysis was performed if there were two or more studies showing information regarding positive-to-negative conversion rates; number of days varied based on reported similarities among chosen studies.",
            "cite_spans": [],
            "section": "Data Collection ::: Methods",
            "ref_spans": []
        },
        {
            "text": "If there were any common endpoints among the trials collected, a meta-analysis would then be performed. Endpoints were related to viral clearance. Statistical analyses used the Review Manager Version 5.3 (The Cochrane Collaboration, Copenhagen, Denmark) software program. A forest plot was created using the program with the DerSimonian and Laird fixed-effects model to reduce heterogeneity. The mean difference with a confidence interval (CI) of 95% was reported with the inverse variance method. Due to using a scale, the value marking no significance via confidence interval was zero. An I2 greater than 50% suggests significant heterogeneity. If there was significant heterogeneity, a random-effects model would be used instead.",
            "cite_spans": [],
            "section": "Statistical Analysis ::: Methods",
            "ref_spans": []
        },
        {
            "text": "A total of 1781 articles were found with the keywords selected. A total of 57 studies were included initially based on title and abstract review. A total of 26 studies were included in the systematic review: Four studies elaborated about lopinavir/ritonavir; four studies studied arbidol, six for hydroxychloroquine, one for remdesivir, six for tocilizumab, two for favipiravir, two for heparin, and one for dexamethasone. Statistical analyses regarding positive-to-negative conversion rates were possible for lopinavir/ritonavir, arbidol, and hydroxychloroquine. No human controlled trials were found for glucocorticoids, interferons, ivermectin, or convalescent plasma. Statistical analysis regarding positive-to-negative conversion rates was possible for lopinavir/ritonavir (two studies), arbidol (two studies), and hydroxychloroquine (four studies) (Fig. 1).",
            "cite_spans": [],
            "section": "Study Selection ::: Results",
            "ref_spans": [
                {
                    "start": 860,
                    "end": 861,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Four controlled trials exist regarding the treatment for COVID-19 (Table 1). Two studies are randomized controlled trials and two are retrospective controlled studies [3\u20136].",
            "cite_spans": [
                {
                    "start": 168,
                    "end": 169,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 170,
                    "end": 171,
                    "mention": "6",
                    "ref_id": "BIBREF55"
                }
            ],
            "section": "Treatment ::: Lopinavir/Ritonavir ::: Results",
            "ref_spans": [
                {
                    "start": 73,
                    "end": 74,
                    "mention": "1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "The most recognized is the randomized, controlled, open-label trial by Cao et al. [3] The study showed no significant difference in terms of 28-day mortality or time of positive-to-negative reverse transcriptase-polymerase chain reaction (RT-PCR) conversion. Lopinavir-ritonavir did reduce the time to clinical improvement by 1 day but was considered marginally non-statistically significant. This study had many limitations. The study was organized as an open label and with lack of placebo. About 14% of trial recipients could not complete a full 14-day treatment course due to adverse medication effects including nausea, vomiting, and diarrhea. However, the incidence of respiratory failure, acute kidney injury, and secondary infection was higher in the standard-care group.",
            "cite_spans": [
                {
                    "start": 83,
                    "end": 84,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                }
            ],
            "section": "Treatment ::: Lopinavir/Ritonavir ::: Results",
            "ref_spans": []
        },
        {
            "text": "Positive-to-negative RT-PCR conversion was not significant with lopinavir-ritonavir (Fig. 2) [3, 4]. There was no significant difference between the study and control group at 14 days (OR 0.95 [95% CI 0.50\u20131.83]). Other retrospective studies suggest earlier clearance with lopinavir-ritonavir but did not report the results at 14 days [5, 6]. Furthermore, the two studies that did suggest clearance are retrospective studies while the other two are randomized controlled trials.",
            "cite_spans": [
                {
                    "start": 94,
                    "end": 95,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 97,
                    "end": 98,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 336,
                    "end": 337,
                    "mention": "5",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 339,
                    "end": 340,
                    "mention": "6",
                    "ref_id": "BIBREF55"
                }
            ],
            "section": "Treatment ::: Lopinavir/Ritonavir ::: Results",
            "ref_spans": [
                {
                    "start": 90,
                    "end": 91,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "The most significant lopinavir/ritonavir side effects include loss of appetite, nausea, vomiting, and diarrhea [3, 4]. Diarrhea can possibly become severe [4]. Apart from elevated transaminase levels, other laboratory markers do not significantly differ from the control group [3, 4].",
            "cite_spans": [
                {
                    "start": 112,
                    "end": 113,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 115,
                    "end": 116,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 156,
                    "end": 157,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 278,
                    "end": 279,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 281,
                    "end": 282,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                }
            ],
            "section": "Adverse Effects ::: Lopinavir/Ritonavir ::: Results",
            "ref_spans": []
        },
        {
            "text": "There are currently four controlled trials discussing the use of arbidol for the treatment of COVID-19 patients (Table 2) [4, 7\u20139]. Two of the trials are randomized while the other two are retrospective studies. Only Li et al. includes a comparison between arbidol and standard supportive therapy [4]. The two retrospective studies include a comparison with lopinavir/ritonavir [8, 9]. Chen et al. compare arbidol with favipiravir [7].",
            "cite_spans": [
                {
                    "start": 123,
                    "end": 124,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 126,
                    "end": 127,
                    "mention": "7",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 128,
                    "end": 129,
                    "mention": "9",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 298,
                    "end": 299,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 379,
                    "end": 380,
                    "mention": "8",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 382,
                    "end": 383,
                    "mention": "9",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 432,
                    "end": 433,
                    "mention": "7",
                    "ref_id": "BIBREF66"
                }
            ],
            "section": "Treatment ::: Umifenovir (Arbidol) ::: Results",
            "ref_spans": [
                {
                    "start": 119,
                    "end": 120,
                    "mention": "2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "Arbidol was commonly compared with lopinavir/ritonavir [4, 9] while there is no difference in positive-to-negative conversion rates between the two medications at the seventh (OR 1.63 [95% CI 0.76\u20133.50]) or 14th day (OR 5.37 [95% CI 0.35\u201383.30]) (Figs. 3 and 4). Of note, for the 14-day comparison, a fixed effect model would show arbidol having more viral clearance compared to lopinavir/ritonavir (OR 5.0 [95% CI 1.50\u201316.64]). However, there was significant heterogeneity between the two studies (I2 = 66%). A random effects model was therefore employed to counter the heterogeneity, resulting in a nonsignificant difference between the two medications.",
            "cite_spans": [
                {
                    "start": 56,
                    "end": 57,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 59,
                    "end": 60,
                    "mention": "9",
                    "ref_id": "BIBREF71"
                }
            ],
            "section": "Treatment ::: Umifenovir (Arbidol) ::: Results",
            "ref_spans": [
                {
                    "start": 253,
                    "end": 254,
                    "mention": "3",
                    "ref_id": "FIGREF2"
                },
                {
                    "start": 259,
                    "end": 260,
                    "mention": "4",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "Adding arbidol with lopinavir/ritonavir did show significant conversion rates and CT scan improvements compared to lopinavir/ritonavir by itself [8].",
            "cite_spans": [
                {
                    "start": 146,
                    "end": 147,
                    "mention": "8",
                    "ref_id": "BIBREF70"
                }
            ],
            "section": "Treatment ::: Umifenovir (Arbidol) ::: Results",
            "ref_spans": []
        },
        {
            "text": "While favipiravir did not show any difference compared to arbidol regarding 7-day recovery rate, it did show faster recovery from fever and cough. There was no difference regarding oxygen and non-invasive positive pressure ventilation use between arbidol and favipiravir [7].",
            "cite_spans": [
                {
                    "start": 272,
                    "end": 273,
                    "mention": "7",
                    "ref_id": "BIBREF66"
                }
            ],
            "section": "Treatment ::: Umifenovir (Arbidol) ::: Results",
            "ref_spans": []
        },
        {
            "text": "Arbidol side effects include nausea and diarrhea [4]. Arbidol demonstrated less hyperuricemia compared to favipiravir (p = 0.0014). Both favipiravir and arbidol did not show any significant difference in abnormal liver function tests, psychiatric symptom reaction, or digestive tract reactions [7].",
            "cite_spans": [
                {
                    "start": 50,
                    "end": 51,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 295,
                    "end": 296,
                    "mention": "7",
                    "ref_id": "BIBREF66"
                }
            ],
            "section": "Adverse Effects ::: Umifenovir (Arbidol) ::: Results",
            "ref_spans": []
        },
        {
            "text": "Six controlled trials exist comparing hydroxychloroquine versus standard therapy (Table 3) [10\u201315]. Three studies were randomized, one was prospective, and two were retrospective studies.",
            "cite_spans": [
                {
                    "start": 92,
                    "end": 94,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 95,
                    "end": 97,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "Treatment ::: Hydroxychloroquine ::: Results",
            "ref_spans": [
                {
                    "start": 88,
                    "end": 89,
                    "mention": "3",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "The data regarding hydroxychloroquine remains equivocal. The three randomized controlled trials present conflicting information regarding significance in clinical improvement and positive-to-negative conversion [10, 11, 13]. Chen Z et al. observed conversion based on CT scan results, but CT scans have a high negative predictive value for COVID-19 during the pandemic [16\u201319]. The prospective trial by Gautret et al. showed earlier conversion with hydroxychloroquine [12]. They included patients that took azithromycin with hydroxychloroquine in their study, but that was not included in this analysis. They have yet to present clinical status changes from their study.",
            "cite_spans": [
                {
                    "start": 212,
                    "end": 214,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 216,
                    "end": 218,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 220,
                    "end": 222,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 370,
                    "end": 372,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 373,
                    "end": 375,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 469,
                    "end": 471,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Treatment ::: Hydroxychloroquine ::: Results",
            "ref_spans": []
        },
        {
            "text": "A retrospective controlled study among veterans showed increased mortality with hydroxychloroquine use. Mechanical ventilation rates were similar among the two study arms [14]. Another retrospective review showed no difference in in-hospital mortality [15].",
            "cite_spans": [
                {
                    "start": 172,
                    "end": 174,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 253,
                    "end": 255,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "Treatment ::: Hydroxychloroquine ::: Results",
            "ref_spans": []
        },
        {
            "text": "The positive-to-negative conversion analysis (Fig. 5) was performed at 6\u20137 days to include all the studies. RT-PCR or CT scans were used to monitor time to COVID-19 resolution. Hydroxychloroquine did not show significant effects on positive-to-negative conversion time compared to standard therapy (OR 2.16 [95% CI 0.80\u20135.84]). With significant heterogeneity (I2 = 56%), a random-effects model was used.",
            "cite_spans": [],
            "section": "Treatment ::: Hydroxychloroquine ::: Results",
            "ref_spans": [
                {
                    "start": 51,
                    "end": 52,
                    "mention": "5",
                    "ref_id": "FIGREF4"
                }
            ]
        },
        {
            "text": "Analyzing the three randomized controlled trials only showed no significant difference between hydroxychloroquine and standard therapy (OR 1.50 [95% CI 0.88\u20132.57]) (Fig. 6) [10, 11, 13]. This was with nonsignificant heterogeneity (I2 = 38%), and therefore a fixed-effects model was kept.",
            "cite_spans": [
                {
                    "start": 174,
                    "end": 176,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 178,
                    "end": 180,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 182,
                    "end": 184,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "Treatment ::: Hydroxychloroquine ::: Results",
            "ref_spans": [
                {
                    "start": 170,
                    "end": 171,
                    "mention": "6",
                    "ref_id": "FIGREF5"
                }
            ]
        },
        {
            "text": "Cardiac complications, including cardiac arrest, were more common with hydroxychloroquine use especially when combined with azithromycin [15]. Gastrointestinal symptoms, including diarrhea and elevated transaminase levels, were mentioned with hydroxychloroquine, but they were not statistically significant compared to the control groups [11, 12, 14].",
            "cite_spans": [
                {
                    "start": 138,
                    "end": 140,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 339,
                    "end": 341,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 343,
                    "end": 345,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 347,
                    "end": 349,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Adverse Effects ::: Hydroxychloroquine ::: Results",
            "ref_spans": []
        },
        {
            "text": "Currently there is only one published controlled trial with remdesivir (Table 4) [20]. The randomized, double-blind, placebo-controlled trial showed no difference in time to clinical improvement compared to the control arm (hazard ratio 1.23 [95% CI 0.87\u20131.75]) [20]. A limitation of the study however was that patients in both groups were permitted concomitant use of lopinavir-ritonavir, interferons, and/or corticosteroids.",
            "cite_spans": [
                {
                    "start": 82,
                    "end": 84,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 263,
                    "end": 265,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Treatment ::: Remdesivir ::: Results",
            "ref_spans": [
                {
                    "start": 78,
                    "end": 79,
                    "mention": "4",
                    "ref_id": "TABREF3"
                }
            ]
        },
        {
            "text": "About 66% who received remdesivir reported an adverse side effect. The most common side effects were constipation, hypoalbuminemia, hypokalemia, anemia, thrombocytopenia, and increased bilirubin [20].",
            "cite_spans": [
                {
                    "start": 196,
                    "end": 198,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Adverse Effects ::: Remdesivir ::: Results",
            "ref_spans": []
        },
        {
            "text": "Six studies assessed the benefits of tocilizumab (Table 5). Tocilizumab presents with mixed results. Half of the studies report no significant benefit compared to standard therapy [21\u201323], while the other half report improvement for severe cases or improved hospital stay, survival, and freedom from ventilation [24\u201326]. No studies assessed the duration of positive-to-negative SARS-CoV2 conversion.",
            "cite_spans": [
                {
                    "start": 181,
                    "end": 183,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 184,
                    "end": 186,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 313,
                    "end": 315,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 316,
                    "end": 318,
                    "mention": "26",
                    "ref_id": "BIBREF18"
                }
            ],
            "section": "Treatment ::: Tocilizumab ::: Results",
            "ref_spans": [
                {
                    "start": 56,
                    "end": 57,
                    "mention": "5",
                    "ref_id": "TABREF4"
                }
            ]
        },
        {
            "text": "The following studies did not report any associated side effects with tocilizumab compared to standard therapy.",
            "cite_spans": [],
            "section": "Adverse Reactions ::: Tocilizumab ::: Results",
            "ref_spans": []
        },
        {
            "text": "There are two controlled trials regarding the use of favipiravir (Table 4) [7, 27]. The first is a randomized controlled trial comparing favipiravir to arbidol for COVID-19 patients [7]. Arbidol effects are similar to standard therapy [4]. The other is an open-label, non-randomized, prospective trial comparing favipiravir versus lopinavir/ritonavir [27]. Lopinavir/ritonavir is also similar to standard therapy [3, 4] (Table 6).",
            "cite_spans": [
                {
                    "start": 76,
                    "end": 77,
                    "mention": "7",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 79,
                    "end": 81,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 183,
                    "end": 184,
                    "mention": "7",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 236,
                    "end": 237,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 352,
                    "end": 354,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 414,
                    "end": 415,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 417,
                    "end": 418,
                    "mention": "4",
                    "ref_id": "BIBREF33"
                }
            ],
            "section": "Treatment ::: Favipiravir ::: Results",
            "ref_spans": [
                {
                    "start": 72,
                    "end": 73,
                    "mention": "4",
                    "ref_id": "TABREF3"
                },
                {
                    "start": 427,
                    "end": 428,
                    "mention": "6",
                    "ref_id": "TABREF5"
                }
            ]
        },
        {
            "text": "Chen et al. showed no significant 7-day recovery rate with favipiravir compared to arbidol. The secondary endpoints of fever and cough relief did resolve significantly sooner with favipiravir compared to arbidol, with fever resolving for all patients at day 4 (versus days 7\u20138) and cough improving at day 8 (versus day 8+). There was no difference regarding oxygen and non-invasive positive pressure ventilation use [7].",
            "cite_spans": [
                {
                    "start": 417,
                    "end": 418,
                    "mention": "7",
                    "ref_id": "BIBREF66"
                }
            ],
            "section": "Treatment ::: Favipiravir ::: Results",
            "ref_spans": []
        },
        {
            "text": "Cai et al. showed faster CT scan improvement and viral clearance with favipiravir compared to lopinavir/ritonavir. At day 14, 32/35 (91.43%) favipiravir subjects had improved chest CT scans compared to 28/45 (62.22%) lopinavir/ritonavir patients (p = 0.004). Viral clearance was sooner at 4 days with favipiravir compared to 11 days with lopinavir/ritonavir (p < 0.001) [27].",
            "cite_spans": [
                {
                    "start": 371,
                    "end": 373,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Treatment ::: Favipiravir ::: Results",
            "ref_spans": []
        },
        {
            "text": "Favipiravir shows a similar side-effect profile as to lopinavir/ritonavir, including nausea, vomiting, diarrhea, rash, and elevated transaminase levels [7, 27]. Compared to arbidol, it increases uric acid levels more. While the side effect profile is similar to lopinavir/ritonavir, the frequency of adverse effects is less with favipiravir [27].",
            "cite_spans": [
                {
                    "start": 153,
                    "end": 154,
                    "mention": "7",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 156,
                    "end": 158,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 342,
                    "end": 344,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Adverse Effects ::: Favipiravir ::: Results",
            "ref_spans": []
        },
        {
            "text": "Two retrospective controlled studies included data regarding heparin use (Table 5) [28, 29]. These studies involved deep vein thrombosis prophylaxis dosing of unfractionated (15,000 IU/day) and low-molecular weight (40\u201360 mg/day) heparin (Table 7).",
            "cite_spans": [
                {
                    "start": 84,
                    "end": 86,
                    "mention": "28",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 88,
                    "end": 90,
                    "mention": "29",
                    "ref_id": "BIBREF21"
                }
            ],
            "section": "Treatment ::: Unfractionated and Low-Molecular Weight Heparin ::: Results",
            "ref_spans": [
                {
                    "start": 80,
                    "end": 81,
                    "mention": "5",
                    "ref_id": "TABREF4"
                },
                {
                    "start": 245,
                    "end": 246,
                    "mention": "7",
                    "ref_id": "TABREF6"
                }
            ]
        },
        {
            "text": "Tang et al. showed no difference in 28-day mortality rates. Most patients received low-molecular weight heparin. They note significant improvement in heparin users among those with severe sepsis-induced intravascular coagulopathy. This was determined by a scoring system utilizing platelet count, prothrombin time, and Sequential Organ Failure Assessment (SOFA) scoring [28].",
            "cite_spans": [
                {
                    "start": 371,
                    "end": 373,
                    "mention": "28",
                    "ref_id": "BIBREF20"
                }
            ],
            "section": "Treatment ::: Unfractionated and Low-Molecular Weight Heparin ::: Results",
            "ref_spans": []
        },
        {
            "text": "Shi et al. showed no difference in outcomes including clinical improvement and positive-to-negative conversion rate. All patients in the study improved [29].",
            "cite_spans": [
                {
                    "start": 153,
                    "end": 155,
                    "mention": "29",
                    "ref_id": "BIBREF21"
                }
            ],
            "section": "Treatment ::: Unfractionated and Low-Molecular Weight Heparin ::: Results",
            "ref_spans": []
        },
        {
            "text": "The studies included in the review did not report adverse effects. However, all heparin medications have well-documented side-effects including hemorrhage, osteoporosis, renal tubular acidosis type 4 with hyperkalemia, and heparin-induced thrombocytopenia [30\u201332]. Adverse effects of low-molecular weight heparin are more common in patients with kidney injury [33]. Deep vein thrombosis prophylaxis presents with a lower rate of side-effects [34].",
            "cite_spans": [
                {
                    "start": 257,
                    "end": 259,
                    "mention": "30",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 260,
                    "end": 262,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 361,
                    "end": 363,
                    "mention": "33",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 443,
                    "end": 445,
                    "mention": "34",
                    "ref_id": "BIBREF27"
                }
            ],
            "section": "Adverse Effects ::: Unfractionated and Low-Molecular Weight Heparin ::: Results",
            "ref_spans": []
        },
        {
            "text": "One large randomized controlled trial, the RECOVERY Trial, found an overall benefit when assessing all COVID19 cases together (Table 8) [35]. While there was no benefit for those without oxygen needs, dexamethasone reduced mortality by one-fifth in patients requiring noninvasive oxygen therapy, and by one-third in those requiring mechanical ventilation. Dexamethasone also reduced hospital length of stay and progression to needing invasive mechanical ventilation.",
            "cite_spans": [
                {
                    "start": 137,
                    "end": 139,
                    "mention": "35",
                    "ref_id": "BIBREF28"
                }
            ],
            "section": "Treatment ::: Dexamethasone ::: Results",
            "ref_spans": [
                {
                    "start": 133,
                    "end": 134,
                    "mention": "8",
                    "ref_id": "TABREF7"
                }
            ]
        },
        {
            "text": "While the RECOVERY trial does not report any adverse reactions compared to the standard therapy, glucocorticoids have multiple side-effects. Adverse reactions from acute use include altered mental status, hyperglycemia, increased risk for infection, hypertension, arrhythmias, and myopathy [36, 37].",
            "cite_spans": [
                {
                    "start": 291,
                    "end": 293,
                    "mention": "36",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 295,
                    "end": 297,
                    "mention": "37",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Adverse Reactions ::: Dexamethasone ::: Results",
            "ref_spans": []
        },
        {
            "text": "The meta-analysis portion of the study has some limitations. The first limitation is the small number of patients in the trials and therefore the overall analysis. Another limitation is the use of surrogate endpoints to complete the meta-analysis. This is regarding the use of CT scan resolution for viral clearance in the hydroxychloroquine analysis. Chest CT scans have significant negative predictive value, but is not directly comparable to RT-PCR [16\u201319]. The endpoints were not well-established among all reviewed medications, making it difficult to compare them between studies.",
            "cite_spans": [
                {
                    "start": 453,
                    "end": 455,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 456,
                    "end": 458,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                }
            ],
            "section": "Limitations ::: Discussion",
            "ref_spans": []
        },
        {
            "text": "Regarding the systematic review, publication bias influences the information presented. Favipiravir trials on COVID-19 only involve those compared with other medications and not with a placebo or supportive therapy control arm. The heparin and dexamethasone studies mainly involved the level of severity of COVID-19 rather than having the infection itself.",
            "cite_spans": [],
            "section": "Limitations ::: Discussion",
            "ref_spans": []
        },
        {
            "text": "Current investigated medications do not hasten viral clearance time. Clinical improvement is equivocal with lopinavir/ritonavir, arbidol, hydroxychloroquine, and remdesivir. Favipiravir shows faster viral clearance and clinical improvement compared to lopinavir/ritonavir and arbidol. Heparin shows benefit in patients with severe COVID-19 infections.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Characteristics of lopinavir/ritonavir studies for COVID-19\nT, treatment group (lopinavir/ritonavir); C, control group",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Characteristics of arbidol studies for COVID-19\nT, testing group; C, control group; LPV/r, lopinavir/ritonavir",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table 3: Characteristics of hydroxychloroquine studies for COVID-19\nT treatment group (hydroxychloroquine); C control group",
            "type": "table"
        },
        "TABREF3": {
            "text": "Table 4: Characteristics of remdesivir studies for COVID-19\nT, treatment group (remdesivir); C, control group",
            "type": "table"
        },
        "TABREF4": {
            "text": "Table 5: Characteristics of tocilizumab studies for COVID-19\nT, treatment group (tocilizumab); C, control group",
            "type": "table"
        },
        "TABREF5": {
            "text": "Table 6: Characteristics of favipiravir studies for COVID-19\nT, treatment group (favipiravir); C, control group",
            "type": "table"
        },
        "TABREF6": {
            "text": "Table 7: Characteristics of heparin studies for COVID-19\nT treatment group (heparin); C control group",
            "type": "table"
        },
        "TABREF7": {
            "text": "Table 8: Characteristics of dexamethasone studies for COVID-19\nT, treatment group (dexamethasone); C, control group",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Fig. 1: PRISMA flowchart revealing study selection process",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Fig. 2: Positive-to-negative RT-PCR conversion of lopinavir/ritonavir versus control at 14 days",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Fig. 3: Positive-to-negative RT-PCR conversion of arbidol versus lopinavir/ritonavir versus at 7 days",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Fig. 4: Positive-to-negative RT-PCR conversion of arbidol versus lopinavir/ritonavir versus at 14 days",
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Fig. 5: Positive-to-negative conversion of hydroxychloroquine versus control at 6\u20137 days",
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Fig. 6: Randomized controlled trials showing positive-to-negative conversion of hydroxychloroquine versus control at 6\u20137 days",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "A novel coronavirus outbreak of global health concern",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "PW",
                    "middle": [],
                    "last": "Horby",
                    "suffix": ""
                },
                {
                    "first": "FG",
                    "middle": [],
                    "last": "Hayden",
                    "suffix": ""
                },
                {
                    "first": "GF",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "470-473",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20)30185-9"
                ]
            }
        },
        "BIBREF1": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in the New York state",
            "authors": [
                {
                    "first": "ES",
                    "middle": [],
                    "last": "Rosenberg",
                    "suffix": ""
                },
                {
                    "first": "EM",
                    "middle": [],
                    "last": "Dufort",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Udo",
                    "suffix": ""
                },
                {
                    "first": "LA",
                    "middle": [],
                    "last": "Wilberschied",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tesoriero",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Weinberg",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kirkwood",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Muse",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "DeHovitz",
                    "suffix": ""
                },
                {
                    "first": "DS",
                    "middle": [],
                    "last": "Blog",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hutton",
                    "suffix": ""
                },
                {
                    "first": "DR",
                    "middle": [],
                    "last": "Holtgrave",
                    "suffix": ""
                },
                {
                    "first": "HA",
                    "middle": [],
                    "last": "Zucker",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "323",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.8630"
                ]
            }
        },
        "BIBREF7": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "1569-1578",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20)31022-9"
                ]
            }
        },
        "BIBREF13": {
            "title": "Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 Registry (SMACORE)",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Colaneri",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bogliolo",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Valsecchi",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sacchi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Zuccaro",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Brandolino",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Montecucco",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Mojoli",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Giusti",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bruno",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Microorganisms",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3390/microorganisms8050695"
                ]
            }
        },
        "BIBREF14": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Capra",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "De Rossi",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Mattioli",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Romanelli",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Scarpazza",
                    "suffix": ""
                },
                {
                    "first": "MP",
                    "middle": [],
                    "last": "Sormani",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Eur J Intern Med",
            "volume": "76",
            "issn": "",
            "pages": "31-35",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ejim.2020.05.009"
                ]
            }
        },
        "BIBREF18": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xiang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Bai",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tu",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Gu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Shang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Qu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zou",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Jia",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Ge",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhan",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Qiu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Jaki",
                    "suffix": ""
                },
                {
                    "first": "FG",
                    "middle": [],
                    "last": "Hayden",
                    "suffix": ""
                },
                {
                    "first": "PW",
                    "middle": [],
                    "last": "Horby",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "",
            "pages": "1787-1799",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2001282"
                ]
            }
        },
        "BIBREF23": {
            "title": "Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels",
            "authors": [
                {
                    "first": "GM",
                    "middle": [],
                    "last": "Bengalorkar",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Sarala",
                    "suffix": ""
                },
                {
                    "first": "PN",
                    "middle": [],
                    "last": "Venkatrathnamma",
                    "suffix": ""
                },
                {
                    "first": "TN",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Pharmacol Pharmacother",
            "volume": "2",
            "issn": "",
            "pages": "266-269",
            "other_ids": {
                "DOI": [
                    "10.4103/0976-500X.85956"
                ]
            }
        },
        "BIBREF24": {
            "title": "Clinical aspects of heparin-induced thrombocytopenia and thrombosis and other side effects of heparin therapy",
            "authors": [
                {
                    "first": "RL",
                    "middle": [],
                    "last": "Bick",
                    "suffix": ""
                },
                {
                    "first": "EP",
                    "middle": [],
                    "last": "Frenkel",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Clin Appl Thromb Hemost",
            "volume": "5",
            "issn": "",
            "pages": "7-15",
            "other_ids": {
                "DOI": [
                    "10.1177/10760296990050S103"
                ]
            }
        },
        "BIBREF25": {
            "title": "Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the seventh ACCP conference on antithrombotic and thrombolytic therapy",
            "authors": [
                {
                    "first": "TE",
                    "middle": [],
                    "last": "Warkentin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Greinacher",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Chest",
            "volume": "126",
            "issn": "",
            "pages": "311-337",
            "other_ids": {
                "DOI": [
                    "10.1378/chest.126.3_suppl.311S"
                ]
            }
        },
        "BIBREF26": {
            "title": "Treatment and prevention of venous thromboembolism",
            "authors": [
                {
                    "first": "RD",
                    "middle": [],
                    "last": "Hull",
                    "suffix": ""
                },
                {
                    "first": "GF",
                    "middle": [],
                    "last": "Pineo",
                    "suffix": ""
                },
                {
                    "first": "KA",
                    "middle": [],
                    "last": "Valentine",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Semin Thromb Hemost",
            "volume": "24",
            "issn": "",
            "pages": "21-31",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Prevention of venous thromboembolism",
            "authors": [
                {
                    "first": "EW",
                    "middle": [],
                    "last": "Salzman",
                    "suffix": ""
                }
            ],
            "year": 1979,
            "venue": "Thromb Haemost",
            "volume": "42",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "Adverse effects of corticosteroids on the cardiovascular system",
            "authors": [
                {
                    "first": "DE",
                    "middle": [],
                    "last": "Sholter",
                    "suffix": ""
                },
                {
                    "first": "PW",
                    "middle": [],
                    "last": "Armstrong",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Can J Cardiol",
            "volume": "16",
            "issn": "",
            "pages": "505-511",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Alternate-day prednisone therapy \u2013 evaluation of delayed hypersensitivity responses, control of disease and steroid side effects",
            "authors": [
                {
                    "first": "RR",
                    "middle": [],
                    "last": "MacGregor",
                    "suffix": ""
                },
                {
                    "first": "JN",
                    "middle": [],
                    "last": "Sheagren",
                    "suffix": ""
                },
                {
                    "first": "MB",
                    "middle": [],
                    "last": "Lipsett",
                    "suffix": ""
                },
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Wolff",
                    "suffix": ""
                }
            ],
            "year": 1969,
            "venue": "N Engl J Med",
            "volume": "280",
            "issn": "",
            "pages": "1427-1431",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJM196906262802601"
                ]
            }
        },
        "BIBREF31": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "A systemic review of lopinavir therapy for SARS coronavirus and MERS coronavirus \u2013 a possible reference for coronavirus disease-19 treatment option",
            "authors": [
                {
                    "first": "TT",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                },
                {
                    "first": "JD",
                    "middle": [],
                    "last": "Qian",
                    "suffix": ""
                },
                {
                    "first": "WY",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "GQ",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "92",
            "issn": "",
            "pages": "556-563",
            "other_ids": {
                "DOI": [
                    "10.1002/jmv.25729"
                ]
            }
        },
        "BIBREF33": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings",
            "authors": [
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "VC",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "IF",
                    "middle": [],
                    "last": "Hung",
                    "suffix": ""
                },
                {
                    "first": "MML",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "KH",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "KS",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Thorax",
            "volume": "59",
            "issn": "",
            "pages": "252-256",
            "other_ids": {
                "DOI": [
                    "10.1136/thorax.2003.012658"
                ]
            }
        },
        "BIBREF36": {
            "title": "Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro",
            "authors": [
                {
                    "first": "KT",
                    "middle": [],
                    "last": "Choy",
                    "suffix": ""
                },
                {
                    "first": "AYL",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kaewpreedee",
                    "suffix": ""
                },
                {
                    "first": "SF",
                    "middle": [],
                    "last": "Sia",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "KPY",
                    "middle": [],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "DKW",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "MCW",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "PPH",
                    "middle": [],
                    "last": "Cheung",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Peiris",
                    "suffix": ""
                },
                {
                    "first": "HL",
                    "middle": [],
                    "last": "Yen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Antivir Res",
            "volume": "178",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.antiviral.2020.104786"
                ]
            }
        },
        "BIBREF37": {
            "title": "Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Brooks",
                    "suffix": ""
                },
                {
                    "first": "EI",
                    "middle": [],
                    "last": "Burtseva",
                    "suffix": ""
                },
                {
                    "first": "PJ",
                    "middle": [],
                    "last": "Ellery",
                    "suffix": ""
                },
                {
                    "first": "GA",
                    "middle": [],
                    "last": "Marsh",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Lew",
                    "suffix": ""
                },
                {
                    "first": "AN",
                    "middle": [],
                    "last": "Slepushkin",
                    "suffix": ""
                },
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Crowe",
                    "suffix": ""
                },
                {
                    "first": "GA",
                    "middle": [],
                    "last": "Tannock",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Med Virol",
            "volume": "84",
            "issn": "",
            "pages": "170-181",
            "other_ids": {
                "DOI": [
                    "10.1002/jmv.22234"
                ]
            }
        },
        "BIBREF38": {
            "title": "Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Khamitov",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Loginova",
                    "suffix": ""
                },
                {
                    "first": "VN",
                    "middle": [],
                    "last": "Shchukina",
                    "suffix": ""
                },
                {
                    "first": "SV",
                    "middle": [],
                    "last": "Borisevich",
                    "suffix": ""
                },
                {
                    "first": "VA",
                    "middle": [],
                    "last": "Maksimov",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Shuster",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Vopr Virusol",
            "volume": "53",
            "issn": "",
            "pages": "9-13",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "Chloroquine and hydroxychloroquine inhibit multiple sites in metabolic pathways leading to neutrophil superoxide release",
            "authors": [
                {
                    "first": "NP",
                    "middle": [],
                    "last": "Hurst",
                    "suffix": ""
                },
                {
                    "first": "JK",
                    "middle": [],
                    "last": "French",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gorjatschko",
                    "suffix": ""
                },
                {
                    "first": "WH",
                    "middle": [],
                    "last": "Betts",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "J Rheumatol",
            "volume": "15",
            "issn": "",
            "pages": "23-27",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "Race to find COVID-19 treatments accelerates",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kupferschmidt",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Science",
            "volume": "367",
            "issn": "",
            "pages": "1412-1413",
            "other_ids": {
                "DOI": [
                    "10.1126/science.367.6485.1412"
                ]
            }
        },
        "BIBREF44": {
            "title": "Clinical efficacy of lopinavir/ritonavir in the treatment of coronavirus disease 2019",
            "authors": [
                {
                    "first": "XT",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "YL",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "QF",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "QF",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "JG",
                    "middle": [],
                    "last": "Ding",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Eur Rev Med Pharmacol Sci",
            "volume": "24",
            "issn": "",
            "pages": "3390-3396",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF45": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF46": {
            "title": "Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia",
            "authors": [],
            "year": 2020,
            "venue": "Zhonghua jie he he hhu xi za zhi (Chinese J Tuberc Respir Dis)",
            "volume": "43",
            "issn": "",
            "pages": "185-188",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF47": {
            "title": "Compassionate use of remdesivir for patients with severe Covid-19",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Grein",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ohmagari",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Shin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Diaz",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Asperges",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Castagna",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Feldt",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Green",
                    "suffix": ""
                },
                {
                    "first": "ML",
                    "middle": [],
                    "last": "Green",
                    "suffix": ""
                },
                {
                    "first": "FX",
                    "middle": [],
                    "last": "Lescure",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Nicastri",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Oda",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yo",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Quiros-Roldan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Studemeister",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Redinski",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ahmed",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bernett",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chelliah",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chihara",
                    "suffix": ""
                },
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cunningham",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "D\u2019Arminio Monforte",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ismail",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kato",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lapadula",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "L\u2019Her",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Maeno",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Majumder",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Massari",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mora-Rillo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Mutoh",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Nguyen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Verweij",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zoufaly",
                    "suffix": ""
                },
                {
                    "first": "AO",
                    "middle": [],
                    "last": "Osinusi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "DeZure",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Chokkalingam",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Elboudwarej",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Telep",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Timbs",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Henne",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sellers",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "SK",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Winterbourne",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Desai",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mera",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gaggar",
                    "suffix": ""
                },
                {
                    "first": "RP",
                    "middle": [],
                    "last": "Myers",
                    "suffix": ""
                },
                {
                    "first": "DM",
                    "middle": [],
                    "last": "Brainard",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Childs",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Flanigan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "",
            "pages": "2327-2336",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2007016"
                ]
            }
        },
        "BIBREF48": {
            "title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell Res",
            "volume": "30",
            "issn": "",
            "pages": "269-271",
            "other_ids": {
                "DOI": [
                    "10.1038/s41422-020-0282-0"
                ]
            }
        },
        "BIBREF49": {
            "title": "Tocilizumab: a review in rheumatoid arthritis",
            "authors": [
                {
                    "first": "LJ",
                    "middle": [],
                    "last": "Scott",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Drugs",
            "volume": "77",
            "issn": "",
            "pages": "1865-1879",
            "other_ids": {
                "DOI": [
                    "10.1007/s40265-017-0829-7"
                ]
            }
        },
        "BIBREF50": {
            "title": "Mechanism of action of T-705 against influenza virus",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Furuta",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Takahashi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kuno-Maekawa",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Sangawa",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Uehara",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kozaki",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Nomura",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Egawa",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Shiraki",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Antimicrob Agents Chemother",
            "volume": "49",
            "issn": "",
            "pages": "981-986",
            "other_ids": {
                "DOI": [
                    "10.1128/AAC.49.3.981-986.2005"
                ]
            }
        },
        "BIBREF51": {
            "title": "The ambiguous base-pairing and high substrate efficiency of T-705 (favipiravir) ribofuranosyl 5\u2032-triphosphate towards influenza A virus polymerase",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "LK",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "VK",
                    "middle": [],
                    "last": "Rajwanshi",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Deval",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "PLoS One",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0068347"
                ]
            }
        },
        "BIBREF52": {
            "title": "T-705 (favipiravir) suppresses tumor necrosis factor alpha production in response to influenza virus infection: a beneficial feature of T-705 as an anti-influenza drug",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tanaka",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kamiyama",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Daikoku",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Takahashi",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Nomura",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kurokawa",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Acta Virol",
            "volume": "61",
            "issn": "",
            "pages": "48-55",
            "other_ids": {
                "DOI": [
                    "10.4149/av_2017_01_48"
                ]
            }
        },
        "BIBREF53": {
            "title": "Negative regulation of lung inflammation and immunopathology by TNF-alpha during acute influenza infection",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Damjanovic",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Divangahi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kugathasan",
                    "suffix": ""
                },
                {
                    "first": "CL",
                    "middle": [],
                    "last": "Small",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zganiacz",
                    "suffix": ""
                },
                {
                    "first": "EG",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Hogaboam",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gauldie",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Xing",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Am J Pathol",
            "volume": "179",
            "issn": "",
            "pages": "2963-2976",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ajpath.2011.09.003"
                ]
            }
        },
        "BIBREF54": {
            "title": "QTc interval prolongation duration favipiravir therapy in an ebolavirus-infected patient",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chinello",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Petrosillo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pittalis",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Biava",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ippolito",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Nicastri",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "PLoS Negl Trop Dis",
            "volume": "11",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pntd.0006034"
                ]
            }
        },
        "BIBREF55": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF56": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF57": {
            "title": "Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Qian",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tian",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J Chron Obstruct Pulmon Dis",
            "volume": "11",
            "issn": "",
            "pages": "171-176",
            "other_ids": {
                "DOI": [
                    "10.3109/15412555.2013.831062"
                ]
            }
        },
        "BIBREF58": {
            "title": "Unfractionated heparin alleviates sepsis-induced acute lung injury by protecting tight junctions",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Surg Res",
            "volume": "238",
            "issn": "",
            "pages": "175-185",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jss.2019.01.020"
                ]
            }
        },
        "BIBREF59": {
            "title": "Unfractionated heparin inhibits lipopolysaccharide-induced expression of chemokines in human endothelial cells through nuclear factor-\u03baB signaling pathway",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Zhonghua Wei Zhong Bing Ji Jiu Yi Xue",
            "volume": "28",
            "issn": "",
            "pages": "117-121",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF60": {
            "title": "Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1\u03b2, IL-6 and IL-8",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bester",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Matshailwe",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Pretorius",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Cytokine",
            "volume": "110",
            "issn": "",
            "pages": "237-242",
            "other_ids": {
                "DOI": [
                    "10.1016/j.cyto.2018.01.007"
                ]
            }
        },
        "BIBREF61": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF62": {
            "title": "Characterization of heparin-binding properties of IL-6",
            "authors": [
                {
                    "first": "RS",
                    "middle": [],
                    "last": "Mummery",
                    "suffix": ""
                },
                {
                    "first": "CC",
                    "middle": [],
                    "last": "Rider",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Immunol",
            "volume": "165",
            "issn": "",
            "pages": "5671-5679",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.165.10.5671"
                ]
            }
        },
        "BIBREF63": {
            "title": "Low-molecular-weight heparin treatment for acute lung injury/acute respiratory distress syndrome: a meta-analysis of randomized controlled trials",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Int J Clin Exp Med",
            "volume": "11",
            "issn": "",
            "pages": "414-422",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF64": {
            "title": "Herpesviruses and heparin sulfate: an intimate relationship in aid of viral entry",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Shukla",
                    "suffix": ""
                },
                {
                    "first": "PG",
                    "middle": [],
                    "last": "Spear",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Clin Invest",
            "volume": "108",
            "issn": "",
            "pages": "503-510",
            "other_ids": {
                "DOI": [
                    "10.1172/JCI200113799"
                ]
            }
        },
        "BIBREF65": {
            "title": "Heparin prevents zika virus induced-cytopathic effects in human neural progenitor cells",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ghezzi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Cooper",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rubio",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Pagani",
                    "suffix": ""
                },
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Capobianchi",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ippolito",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Pelletier",
                    "suffix": ""
                },
                {
                    "first": "MCZ",
                    "middle": [],
                    "last": "Meneghetti",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Lima",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Skidmore",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Broccoli",
                    "suffix": ""
                },
                {
                    "first": "EA",
                    "middle": [],
                    "last": "Yates",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vicenzi",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Antiviral Re",
            "volume": "140",
            "issn": "",
            "pages": "13-17",
            "other_ids": {
                "DOI": [
                    "10.1016/j.antiviral.2016.12.023"
                ]
            }
        },
        "BIBREF66": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF67": {
            "title": "Coronaviridae and SARS-associated coronavirus strain HSR1",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vicenzi",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Canducci",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Pinna",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Mancini",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Carletti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lazzarin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bordignon",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Poli",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Clementi",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Emerg Infect Dis",
            "volume": "10",
            "issn": "",
            "pages": "413-418",
            "other_ids": {
                "DOI": [
                    "10.3201/eid1003.030683"
                ]
            }
        },
        "BIBREF68": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF69": {
            "title": "COVID-19: consider cytokine storm syndromes and immunosuppression",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Mehta",
                    "suffix": ""
                },
                {
                    "first": "DF",
                    "middle": [],
                    "last": "McAuley",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Sanchez",
                    "suffix": ""
                },
                {
                    "first": "RS",
                    "middle": [],
                    "last": "Tattersall",
                    "suffix": ""
                },
                {
                    "first": "JJ",
                    "middle": [],
                    "last": "Manson",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "1033-1034",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20)30628-0"
                ]
            }
        },
        "BIBREF70": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF71": {
            "title": "Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Zha",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Xue",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Inf Secur",
            "volume": "81",
            "issn": "",
            "pages": "e21-e23",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jinf.2020.03.060"
                ]
            }
        }
    }
}